Home > Boards > US OTC > Banking and Finance > Lans Holdings Inc. (LAHO)

$LAHO..RM..GSCG..$600 Billion Investments..BOFA Goldman..

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ApollyonZ Member Profile
 
Followed By 72
Posts 2,363
Boards Moderated 2
Alias Born 08/11/17
160x600 placeholder
ApollyonZ   Friday, 08/16/19 10:08:15 AM
Re: None
Post # of 58156 
$LAHO..RM..GSCG..$600 Billion Investments..BOFA Goldman..

Lans Holdings, Inc.

Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com

For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451

https://www.otcmarkets.com/stock/LAHO/disclosure

..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.

https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069


..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/

SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.

Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group

https://www.otcmarkets.com/stock/LAHO/news



$24.4M Zoominfo Prior Q

https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775

AdiMarket $10M




1 of 27 Facilities, Stem Cells Group Chile $5.6M!


We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.

http://www.stemcellsgroup.com/adimarket-launches-website/

..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians

http://stemcellcenter.net/

ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE

https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf

GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!


GCSG is #1 competitor for Beike Biotechnology.


Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.

https://beikebiotech.com



GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China

..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.

..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.

http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/

Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.

ZhangM3

..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...

https://www.ncbi.nlm.nih.gov/pubmed/28353401

GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!


Advisory board!

http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/

GSCG TREATING FORMER NFL PRO!


https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473




GSCG Office $167k per year, Top Location!!!

$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k

https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/



http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373

https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06



http://www.lans.holdings/

..upsurge in venture capital investment represents growth of 7,300%

https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html

Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020


Stem cells: THE FUTURE OF MEDICINE

Over the last decade, the number of publications per year on stem cell-related research has increased 40x.

https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp

Regenerative medicine will dramatically alter the U.S. healthcare industry

..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..

An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:

250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually

..By doing so, we can make tissue and organ failure a relic of the past by 2020.

Interagency Federal Working Group on Regenerative Medicine



Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services

National Institutes of Health

Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD

Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD

http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html

Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.

Money is pouring in to a hot new area of science that could change the way we think about aging

.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.

https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html

$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..



..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..

https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/



Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.

https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05

..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27

The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.

Sector Healthcare: 30.50
Sector Technology: 34.40

https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/

BioTechnology


https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503

Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World

What Does Pfizer Have to do with the World of Stem Cells?

Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.

https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/

PFIZER ACQUIRES A STEM-CELL THERAPY

But as the science of stem cells has advanced, drug companies are taking an interest.

http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/


GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!


https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com

Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.

Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas

Bar Admissions:

State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court


CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018

https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381

..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html

“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive

Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/

CONSUMER REPORT..stem cells market. a whole lot of demand

https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/

STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html

Amag Pharma..buy world's largest stem..bank..$700 million

..and that it was on the hunt for more deals.

https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html

Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs

https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives





GSCG conference in Japan..

..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto
.

The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.

The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.

..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.

https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/


https://time.com/5394912/stem-cell-treatment/?amp=true

Harvard team grows cyborg mini-organs out of stem cells

https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/

Stem cells The Holy Grail Stansberry report!

..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...

First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.

To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.

This may sound like science fiction. But it's not...

Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...

This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.

There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.

So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.

https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2

Oxford University

One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.

..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.

https://www.stemcells.ox.ac.uk/home

Stem Cells Are Poised to Change Health and Medicine Forever

https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/

..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..

https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198

..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.

https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp

..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”

https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html

Johns Hopkins

The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done

https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html

Harvard Stem Cell

..Our mission is to find cures for human diseases.

The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me

https://hsci.harvard.edu

Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells

For a limited time promotional shipping rates are available on most orders over $ 5000 .

https://www.adimarket.net/how-to-order/


Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/

Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.

https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine





Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.

https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/

Adimarket, has announced an agreement with biotechnology company Alolotl Biologix

..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.

Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties

https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/

Hair Transplant Market worth over $24.8 billion by 2024:

https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html


Drug companies chase deals for cell and gene therapies, biotech's 'next wave'

..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."

https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2

..Stem Cell Banking Market to Witness Astonishing Growth

https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/

..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine

https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.



Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..

http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2


https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm

GSCG ISSCA Launch Dates.

•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212

..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!

Mayo Clinic uses stem cell therapy to treat arthritis in knee

http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee


Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827

Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/

Nearly a decade of stem cell therapy experience

The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.

http://cellgenic.com/

Cellgenic Catalogue!

$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing


The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.

http://cellgenic.com/

Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing

$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived

https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/

Global Stem Cells Group to Break Ground on New Lab in Mexico

..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials

https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-

CELLGENIC












http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/

Exosomes are currently non-reactive and FDA approved.

ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.


..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise

LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain

..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”


https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239



NASA and Techshot Trying To 3D Print Organs In Space


https://www.nasa.gov/mission_pages/station/research/news/spx18-research

..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/

3D Bioprinting Market To Reach USD 4.40 Billion

.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.

https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html

....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..




https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal

LAHO CEO Dave Christensen highly skilled.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841

..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/

Adimarket featured products!

Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER

BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/

Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/

Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas

..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .

https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-

http://www.stemcellsgroup.com/adimarket-launches-website/



..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).

https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25

Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/

Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116

Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta

Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..

https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/

“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”

In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.

https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com





Barcelona, Spain

J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.


http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\

Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine

https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/

GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center

..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT

The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.

https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/


....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/



Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.

..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA

..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).

Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.

Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.

http://www.stemcellsgroup.com/advisory-board/



Global Stem Cells Group to Break Ground on New Lab in Mexico

..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials


https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-

Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/

https://www.facebook.com/globalstemcells/


Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.

http://stemdata.org

LAB FACILITY AND EQUIPMENT

http://stemcellslab.net/facility-and-equipment/

JAPAN IN PROGRESS



http://stemcellslab.net/project-plan/

GSCG Provider Testimonials

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068

BUSINESS OPPORTUNITY



State-Of-The-Art Equipment

We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..

http://stemcellslab.net/facility-and-equipment/


http://stemcellcenter.net/programs/

$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH.

QUOD ERAT DEMONSTRANDUM GLTA



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist